Pasca Ludovica, Ferraris Cinzia, Guglielmetti Monica, Varesio Costanza, Totaro Martina, Trentani Claudia, Marazzi Claudia, Brambilla Ilaria, Ballante Elena, Armeno Marisa, Valenzuela Gabriela Reyes, Caraballo Roberto H, Veggiotti Pierangelo, Tagliabue Anna, De Giorgis Valentina
Department of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Front Nutr. 2023 Jul 27;10:1188055. doi: 10.3389/fnut.2023.1188055. eCollection 2023.
Ketogenic dietary therapies (KDT) are well-established, safe, non-pharmacologic treatments used for children and adults with drug-resistant epilepsy and other neurological disorders. Ketone bodies (KBs) levels are recognized as helpful to check compliance to the KDT and to attempt titration of the diet according to the individualized needs. KBs might undergo inter-individual and intra-individual variability and can be affected by several factors. Possible variations in glycemia and ketone bodies blood levels according to the menstrual cycle have not been systematically assessed yet, but this time window deserves special attention because of hormonal and metabolic related changes.
This study aims at searching for subtle changes in KBs blood level during menstrual cycle in female patients undergoing a stable ketogenic diet, by analyzing 3-months daily measurement of ketone bodies blood levels and glucose blood levels throughout the menstrual cycle.
We report the preliminary results on six female patients affected by GLUT1DS or drug resistant epilepsy, undergoing a stable classic ketogenic diet. A significant increase in glucose blood levels during menstruation was found in the entire cohort. As far as the ketone bodies blood levels, an inversely proportional trend compared to glycemia was noted.
Exploring whether ketonemia variations might occur according to the menstrual cycle is relevant to determine the feasibility of transient preventive diet adjustments to assure a continuative treatment efficacy and to enhance dietary behavior support.
clinicaltrials.gov, identifier NCT05234411.
生酮饮食疗法(KDT)是成熟、安全的非药物治疗方法,用于患有耐药性癫痫和其他神经系统疾病的儿童和成人。酮体(KBs)水平有助于检查对KDT的依从性,并根据个体需求尝试调整饮食。KBs可能存在个体间和个体内差异,并可能受到多种因素影响。月经周期对血糖和血酮体水平的潜在影响尚未得到系统评估,但由于激素和代谢相关变化,这一时期值得特别关注。
本研究旨在通过分析女性患者在整个月经周期中连续3个月每日的血酮体和血糖水平测量值,探寻接受稳定生酮饮食的女性患者在月经周期中血酮体水平的细微变化。
我们报告了6例患有葡萄糖转运体1缺陷综合征(GLUT1DS)或耐药性癫痫且正在接受稳定经典生酮饮食的女性患者的初步结果。整个队列中,月经期间血糖水平显著升高。就血酮体水平而言,观察到其与血糖呈反比趋势。
探究血酮水平是否会随月经周期变化,对于确定临时预防性饮食调整的可行性至关重要,这有助于确保持续的治疗效果并加强饮食行为支持。
clinicaltrials.gov,标识符NCT05234411。